Barclays analyst Matt Miksic raised the firm’s price target on Edwards Lifesciences (EW) to $88 from $85 and keeps an Overweight rating on the ...

Edwards Lifesciences (EW – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Larry ...

Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of ...

Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") of a class action securities ...

Edwards Lifesciences' (NYSE:EW) stock is up by 4.0% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, ...

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2024 earnings per ...

In a landmark decision (UPC_CFI_15/2023) delivered on November 15, 2024, the Unified Patent Court's Local Division in Munich (UPC, LDM) ruled in ...

Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Royal Bank of Canada from $75.00 to $80.00 in a report issued on Wednesday,Benzinga reports.They currently have an ...

Edwards Lifesciences' estimated fair value is US$69.12 based on 2 Stage Free Cash Flow to Equity Edwards Lifesciences' US$71.27 share price indicates it is trading at similar levels as its fair value ...

On Wednesday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $72.07 which represents a slight increase of $0.52 or 0.73% from the prior close of $71.55. The stock opened ...